Blue Cross Blue Shield Updates Coverage and Prior Authorization Policies
Blue Cross Blue Shield Revamps Coverage and Authorization Policies
Starting January 1, 2026, Blue Cross and Blue Care Network will implement significant changes to their coverage of continuous glucose monitoring (CGM) products. These policy updates will impact CGM product processing through pharmacies and durable medical equipment providers. Additionally, new AI-driven prior authorization protocols began on November 2, 2025, affecting Medicare Plus Blue, BCN commercial, and BCN Advantage members, specifically altering services that require authorization.
To address regulatory compliance requirements and optimize claim processing, all claims for Medicare-covered services under Medicare Advantage PPO plans must now include the National Provider Identification (NPI) number of the ordering or referring physician. This adjustment is designed to minimize authorization delays and prevent unnecessary claims denials within the payer landscape.
HAP Enhances Digital Platforms and Updates Provider Guidelines
Embracing CMS interoperability advancements, HAP will unveil a new digital prior authorization platform in spring 2026. Powered by EPIC’s Tapestry Link system, this tool will replace the CareAffiliate application, streamlining user identity verification through enhanced risk management practices. Although personal information verification will be required, providers who do not submit prior authorizations can opt out of providing personal details.
Moreover, the HAP Provider Manual will be revised on February 1, 2026, especially in the areas of anesthesia and interventional pain management. These changes are part of ongoing efforts to tailor policies to fit specific practices within the medical carrier industry.
Medicare Participation and Telehealth Compliance
The deadline for Medicare participation decisions for the 2026 calendar year ends on December 31, 2025. Providers who wish to maintain their current participation status need not take any additional action during this period. Awareness of these deadlines is crucial for compliance and regulatory adherence in the provider sector.
Significant regulatory changes also come from CMS with new telehealth guidelines effective January 30, 2026. An in-person, non-telehealth visit will now be mandatory, influencing provider-payer dynamics and ensuring adherence to updated telehealth standards.